 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Cepheid Joins Attack on Roche PCR Patents with Lawsuit; Roche Expects Arbitration to Play Out
August 30, 2012
Cepheid Joins Attack on Roche PCR Patents with Lawsuit; Roche Expects Arbitration to Play Out
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche Wins One Battle, Delays Another in PCR Patent Legal Row with Cepheid
January 24, 2013 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - In Cepheid v. Roche IP Suit, Court Delays Hearing on One Patent, Dismisses Second Patent from Case
January 18, 2013 / GenomeWeb Daily News - JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark
January 9, 2013 / GenomeWeb Daily News